Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)

Expertise: no longer a sine qua non for guideline authors? (2017) Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, et al. Journal article, Editorial The winner takes it all? Characteristics of adolescent at-risk/problem gamblers in Switzerland. (2016) Lehmann S, Akre C, Berchtold A, Flatz A, Suris JC Journal article Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta (2016) Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, Popp J Journal article Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke (2016) Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, et al. Journal article Complex reinnervation pattern after unilateral renal denervation in rats (2016) Rodionova K, Fiedler C, Günther F, Grouzmann E, Neuhuber W, Fischer M, Ott C, et al. Journal article Repeated Intravenous Thrombolysis for Early Recurrent Stroke: Challenging the Exclusion Criterion (2016) Kahles T, Mono ML, Heldner MR, Baumgartner RW, Sarikaya H, Luft A, Bohlhalter S, et al. Journal article KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference (2016) Schumann G, Liu C, O'Reilly P, Gao H, Song P, Xu B, Ruggeri B, et al. Journal article Elevated serum levels of free interleukin-18 in adult-onset Still's disease (2016) Girard C, Rech J, Brown M, Allali D, Roux-Lombard P, Spertini F, Schiffrin EJ, et al. Journal article International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus (2015) Moehler M, Baltin CT, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, et al. Journal article MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive Glioblastoma: The DIRECTOR Trial (2015) Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, et al. Journal article